Surveillance and Outcomes of Pediatric Hematopoietic Stem Cell Transplantation Recipients During the Recent COVID-19 Outbreak in China

References

• Menni C, Valdes AM, Polidori L, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022;399(10335):1618–1624. doi:10.1016/s0140-6736(22)00327-0
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Eng J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
   PubMed Web of Science ®Google Scholar
• Howard-Jones AR, Bowen AC, Danchin M, et al. COVID-19 in children: i. Epidemiology, prevention and indirect impacts. J Paediatr Child Health. 2022;58(1):39–45. doi:10.1111/jpc.15791
   PubMed Web of Science ®Google Scholar
• Howard-Jones AR, Burgner DP, Crawford NW, et al. COVID-19 in children. II: pathogenesis, disease spectrum and management. J Paediatr Child Health. 2022;58(1):46–53. doi:10.1111/jpc.15811
   PubMed Web of Science ®Google Scholar
• Vicent MG, Martinez AP, Trabazo Del Castillo M, et al. COVID-19 in pediatric hematopoietic stem cell transplantation: the experience of Spanish Group of Transplant (GETMON/GETH). Pediatr Blood Cancer. 2020;67(9):e28514. doi:10.1002/pbc.28514
   PubMed Web of Science ®Google Scholar
• Mobile RZ, Warnawin S, Kojo TK, et al. SARS-CoV-2 in saliva, viremia and seroprevalence for COVID-19 surveillance at a single hematopoietic stem cell transplantation center: a prospective cohort study. Rev Inst Med Trop Sao Paulo. 2022:64:e39. doi:10.1590/s1678-9946202264039
   PubMed Web of Science ®Google Scholar
• Bhatt NS, Sharma A, St Martin A, et al. Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: a Cohort Study. Transplant Cell Ther. 2022;28(10):696.e1–696.e7. doi:10.1016/j.jtct.2022.06.026
   PubMedGoogle Scholar
• Dallas RH. #46 A Multicenter Study Exploring the Epidemiology and Outcomes of COVID-19 Among Pediatric Hematopoietic Cell Transplant, Cellular Therapy and Solid Organ Transplant Recipients: preliminary Results from the Pediatric COVID-19 U.S. Registry. J Pediatric Infectious Dis Society. 2022;11(Supplement_1):S2–S3. doi:10.1093/jpids/piac041.007
   Google Scholar
• Cesaro S, Ljungman P, Mikulska M, et al. Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9). Leukemia. 2022;36(6):1467–1480. doi:10.1038/s41375-022-01578-1
   PubMed Web of Science ®Google Scholar
• Liu Y, Zheng F, Du Z, et al. Evaluation of China’s Hubei control strategy for COVID-19 epidemic: an observational study. BMC Infect Dis. 2021;21(1):820. doi:10.1186/s12879-021-06502-z
   PubMed Web of Science ®Google Scholar
• Zheng Z, Lu Y, Wang M, et al. Low COVID-19 vaccine coverage and guardian acceptance among pediatric transplant recipients. J med virol. 2023;95(1):e28377. doi:10.1002/jmv.28377
   PubMed Web of Science ®Google Scholar
• Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020. doi:10.1001/jama.2020.2648
   PubMed Web of Science ®Google Scholar
• Merli M, Perricone G, Lauterio A, et al. Coronaviruses and Immunosuppressed Patients: the Facts During the Third Epidemic. Liver Transpl. 2020;26(11):1543–1544. doi:10.1002/lt.25806
   PubMed Web of Science ®Google Scholar
• Averbuch D, de la Camara R, Tridello G, et al. Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study. Bone Marrow Transplant. 2023;58(5):558–566. doi:10.1038/s41409-023-01941-5
   PubMed Web of Science ®Google Scholar
• Balduzzi A, Brivio E, Rovelli A, et al. Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati. Bone Marrow Transplant. 2020;55(10):1900–1905. doi:10.1038/s41409-020-0895-4
   PubMed Web of Science ®Google Scholar
• Sharma A, Bhatt NS, St Martin A, et al. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. Lancet Haematol. 2021;8(3):e185–e193. doi:10.1016/s2352-3026(20)30429-4
   PubMed Web of Science ®Google Scholar
• Ljungman P, Tridello G, Piñana JL, et al. Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry. Front Immunol. 2023;14:1125824. doi:10.3389/fimmu.2023.1125824
   PubMed Web of Science ®Google Scholar
• Kebudi R, Kurucu N, Tuğcu D, et al. COVID-19 infection in children with cancer and stem cell transplant recipients in Turkey: a nationwide study. Pediatr Blood Cancer. 2021;68(6):e28915. doi:10.1002/pbc.28915
   PubMed Web of Science ®Google Scholar
• Velardi E, Tsai JJ, van den Brink MRM. T cell regeneration after immunological injury. Nat Rev Immunol. 2021;21(5):277–291. doi:10.1038/s41577-020-00457-z
   PubMed Web of Science ®Google Scholar
• Bhatt ST, Bednarski JJ. Immune Reconstitution in Pediatric Patients Following Hematopoietic Cell Transplant for Non-malignant Disorders. Front Immunol. 2020;11:1988. doi:10.3389/fimmu.2020.01988
   PubMed Web of Science ®Google Scholar
• Naik S, Vasileiou S, Aguayo-Hiraldo P, et al. Toward Functional Immune Monitoring in Allogeneic Stem Cell Transplant Recipients. Biol Blood Marrow Transplantation. 2020;26(5):911–919. doi:10.1016/j.bbmt.2020.01.005
   PubMed Web of Science ®Google Scholar
• Piñana JL, Pérez A, Chorão P, et al. Respiratory virus infections after allogeneic stem cell transplantation: current understanding, knowledge gaps, and recent advances. Transplant Infectious Dis. 2023:e14117. doi:10.1111/tid.14117
   PubMed Web of Science ®Google Scholar
• Al-Ramahi JS, Shahzad M, Li K, et al. Lessons learned from COVID-19 pandemic: outcomes after SARS-CoV-2 infection in hematopoietic cell transplant and cell therapy recipients. Leukemia Lymphoma. 2023:1–11. doi:10.1080/10428194.2023.2243355
   PubMedGoogle Scholar
• Lin CY, Chien HJ. Acute exacerbation of ocular graft-versus-host disease and anterior uveitis after COVID-19 vaccination. BMC Ophthalmol. 2023;23(1):360. doi:10.1186/s12886-023-03103-z
   PubMed Web of Science ®Google Scholar
• Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi:10.1136/bmj.m3026
   PubMed Web of Science ®Google Scholar
• Zimmermann P, Pittet LF, Finn A, Pollard AJ, Curtis N. Should children be vaccinated against COVID-19? Arch Dis Child. 2022;107(3):e1. doi:10.1136/archdischild-2021-323040
   PubMed Web of Science ®Google Scholar
• Altmann DM, Boyton RJ. COVID-19 vaccination: the road ahead. Science. 2022;375(6585):1127–1132. doi:10.1126/science.abn1755
   PubMed Web of Science ®Google Scholar
• Mohamed K, Rzymski P, Islam MS, et al. COVID-19 vaccinations: the unknowns, challenges, and hopes. J med virol. 2022;94(4):1336–1349. doi:10.1002/jmv.27487
   PubMed Web of Science ®Google Scholar
• Áñez G, Dunkle LM, Gay CL, et al. Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents: a Randomized Clinical Trial. JAMA Netw Open. 2023;6(4):e239135. doi:10.1001/jamanetworkopen.2023.9135
   PubMed Web of Science ®Google Scholar
• Doucette EJ, Gray J, Fonseca K, et al. A longitudinal seroepidemiology study to evaluate antibody response to SARS-CoV-2 virus infection and vaccination in children in Calgary, Canada from July 2020 to April 2022: Alberta COVID-19 Childhood Cohort (AB3C) Study. PLoS One. 2023;18(4):e0284046. doi:10.1371/journal.pone.0284046
   PubMed Web of Science ®Google Scholar
• Sadeghi S, Kalantari Y, Shokri S, et al. Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2-21 years old: a Systematic Review and Meta-analysis. J clin virol. 2022;153:105196. doi:10.1016/j.jcv.2022.105196
   PubMed Web of Science ®Google Scholar
• Lee A, Wong SY, Chai LYA, et al. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ. 2022;376:e068632. doi:10.1136/bmj-2021-068632
   PubMedGoogle Scholar
• Wen W, Chen C, Tang J, et al. Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19: a meta-analysis. Ann Med. 2022;54(1):516–523. doi:10.1080/07853890.2022.2034936
   PubMed Web of Science ®Google Scholar
• Saravolatz LD, Depcinski S, Sharma M. Molnupiravir and Nirmatrelvir-Ritonavir: oral Coronavirus Disease 2019 Antiviral Drugs. Clin Infect Dis. 2023;76(1):165–171. doi:10.1093/cid/ciac180
   PubMed Web of Science ®Google Scholar
• Yan G, Zhou J, Zhu H, et al. The feasibility, safety, and efficacy of Paxlovid treatment in SARS-CoV-2-infected children aged 6-14 years: a cohort study. Ann Transl Med. 2022;10(11):619. doi:10.21037/atm-22-2791
   PubMed Web of Science ®Google Scholar
• Attaway AH, Scheraga RG, Bhimraj A, Biehl M, Hatipoğlu U. Severe covid-19 pneumonia: pathogenesis and clinical management. BMJ. 2021;372:n436. doi:10.1136/bmj.n436
   PubMed Web of Science ®Google Scholar
• Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19. Int J Mol Sci. 2022;23(3). doi:10.3390/ijms23031716
   Web of Science ®Google Scholar
• Jeronimo CMP, Farias MEL, Val FFA, et al. Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): a Randomized, Double-blind, Phase IIb, Placebo-controlled Trial. Clin Infect Dis. 2021;72(9):e373–e381. doi:10.1093/cid/ciaa1177
   PubMed Web of Science ®Google Scholar
• Coomes EA, Haghbayan H. Interleukin-6 in Covid-19: a systematic review and meta-analysis. Rev Med Virol. 2020;30(6):1–9. doi:10.1002/rmv.2141
   PubMed Web of Science ®Google Scholar
• Lanzoni G, Linetsky E, Correa D, et al. Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: a double-blind, Phase 1/2a, randomized controlled trial. Stem Cells Translational Med. 2021;10(5):660–673. doi:10.1002/sctm.20-0472
   PubMed Web of Science ®Google Scholar
• Shu L, Niu C, Li R, et al. Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells. Stem Cell Res Ther. 2020;11(1):361. doi:10.1186/s13287-020-01875-5
   PubMed Web of Science ®Google Scholar
• Sengupta V, Sengupta S, Lazo A, Woods P, Nolan A, Bremer N. Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19. Stem Cells Dev. 2020;29(12):747–754. doi:10.1089/scd.2020.0080
   PubMed Web of Science ®Google Scholar